Introduction
The acute phase protein response is part of a non-specific and complex host response to inflammation. It occurs shortly after tissue injury and may be induced by a range of different causes, including infectious, inflammatory, neoplastic, traumatic or immunological disease.
It is mediated by pro-inflammatory cytokines such as interleukin-1 (IL-1), tumour necrosis factor-alpha (TNFα) and interleukin 6 (IL-6) ( Acute phase proteins (APP) demonstrate major, moderate and minor response levels, and these vary between species (Eckersall and Bell 2010). An APP with a major response is one that has a low concentration in healthy animals, but will show a dramatic rise (100-1000-fold) on stimulation with a peak between 24-48 hours and then a rapid decline. A moderate response APP will increase 5-10 fold following stimulation, can take 48-72 hours to peak and will decrease more slowly. A minor response APP will increase only slowly, and only up to twice it's resting level. In dogs, major response APPs include C-reactive protein (CRP) and serum amyloid A (SAA), while moderate responders include alpha-1 acid glycoprotein (AGP) and haptoglobin (Hp). Acute phase proteins can also be divided into positive and negative 
Materials and Methods
Client-owned dogs referred to the authors' institution for treatment of cutaneous MCTs (n=20) and sarcomas (n=21) were prospectively enrolled in the study. Cases were only enrolled in the study if blood sampling formed part of the clinical investigation and/or treatment, and where residual blood was available after diagnostic sampling which would otherwise have been disposed of as clinical waste. Criteria for inclusion in the study were that the patient was not currently being treated with steroids, did not have a recent history of infectious or inflammatory disease other than the tumour, a definitive histological diagnosis was available for the tumour and a full staging procedure was completed prior to surgery using standard oncological protocols to identify metastatic disease where present. karyomegaly (ie, nuclear diameters of at least 10% of neoplastic cells vary by at least twofold). Fields with the highest mitotic activity or with the highest degree of anisokaryosis are used to assess the different parameters. aAlthough this newer system has the advantage of greater simplicity it was not applied retrospectively to the cases in this study.
The sarcoma group included soft tissue sarcoma (4), fibrosarcoma (2), haemangiosarcoma (5), chondrosarcoma (2), osteosarcoma (7), histiocytic sarcoma (1) and poorly differentiated sarcoma (2). Although the variety in histological type in this group meant that a single grading system such as that proposed by Dennis and co-workers in 2010 for soft tissue sarcoma could not be used, each tumour was assigned a subjective grade by the pathologist who assessed the slides, based on well-established histological markers of malignancy such as mitotic index and degree of differentiation. Normal values used by the laboratory for each APP that formed part of the profile were based on samples previously collected from healthy dogs (CRP n=51, HP n=54, SAA n=39, AGP n=37).
Statistical analysis
All comparisons using continuous data were checked for normality and equality of variances and appropriate statistical tests were employed. In order to test the hypothesis that APP concentrations in dogs with MCT or sarcoma were significantly different from normal reference ranges for each APP, we calculated a student's t test (operationalised as a twosample Welch's test for samples of unequal sizes and variances) of whether the means of two independent, normally distributed populations were equal.
In order to test the hypothesis that APP concentrations were significantly different in dogs with different grades of tumour Mann-Whitney tests were used. In order to test the hypothesis that dogs with APP concentrations above the normal reference range for each APP were associated with MCT or sarcoma grade Chi-square tests or Fishers exact tests were used, where appropriate.
Results
Hypothesis 1: APP concentrations in dogs with MCT or sarcoma are significantly different from the normal reference ranges for each APP (table 1.).
CRP concentration was statistically significantly greater than reference range CRP in dogs with MCT (p-value <= 0.00) and sarcoma (p-value = 0.02). Hp concentration was significantly greater than reference range Hp in dogs with sarcoma (p-value <= 0.00), but not
Comment [KP1]:
The individual who provided statistical advice has indicated that they think it is more appropriate to maintain the text p<0.00 rather than saying p<0.01 as per the reviewers request. We will leave this to an editorial decision. Table 3 ) and both grade 1 and grade 2 sarcoma had more cases falling in the SAA negative group with values below the normal reference range.
Discussion
Patients with neoplastic disease often have altered immune status, such that a greater response than normal can be expected to challenges to the immune system (Duthie and 
Conclusions:
The numbers in our groups were small which compromises the validity of statistical evaluation so our results must be interpreted with caution. However some interesting relationships have emerged from the initial evaluation. Our findings suggest that specific combinations of serum APPs for MCTs and sarcomas may be useful as a screening test for the presence of disease. For patients with MCTs, CRP and AGP levels would be expected to increase, with a concurrent drop in SAA levels. In sarcoma patients CRP, AGP and Hp can all be expected to increase. These initial results need to be evaluated in larger numbers of cases with naturally occurring disease to validate the findings. Further areas for investigation include assessment of correlation between APP levels and presence of metastatic disease, and whether the APP values alter following surgery as has been documented in people. 
